Legend Biotech posted Q3 2025 EPS of -$0.11 and revenue of $272.33 million, supported by strong demand for CARVYKTI®.
November 12, 2025
Legend Biotech Corporation has reported impressive financial outcomes for Q1, with CARVYKTI net trade sales reaching approximately $157 million.
May 13, 2024
Back to tokenist.com
467 free spots remaining
By reading Five Minute Finance each week, I learn about new trends before anyone else. I can’t emphasize enough how valuable that is.
Isaiah B.
Five Minute Finance has influenced how I see finance - I rely on it for insight on the latest news and trends at the intersection of finance and technology.
Monica P.
Back to tokenist.com
467 free spots remaining
By reading Five Minute Finance each week, I learn about new trends before anyone else. I can’t emphasize enough how valuable that is.
Isaiah B.
Five Minute Finance has influenced how I see finance - I rely on it for insight on the latest news and trends at the intersection of finance and technology.
Monica P.